186 related articles for article (PubMed ID: 28892223)
1. Dehydroepiandrosterone as a potential agent to slow down ovarian aging.
Lin LT; Cheng JT; Wang PH; Li CJ; Tsui KH
J Obstet Gynaecol Res; 2017 Dec; 43(12):1855-1862. PubMed ID: 28892223
[TBL] [Abstract][Full Text] [Related]
2. The Application of Dehydroepiandrosterone on Improving Mitochondrial Function and Reducing Apoptosis of Cumulus Cells in Poor Ovarian Responders.
Lin LT; Wang PH; Wen ZH; Li CJ; Chen SN; Tsai EM; Cheng JT; Tsui KH
Int J Med Sci; 2017; 14(6):585-594. PubMed ID: 28638275
[TBL] [Abstract][Full Text] [Related]
3. The effect of dehydroepiandrosterone supplementation on ovarian response is associated with androgen receptor in diminished ovarian reserve women.
Hu Q; Hong L; Nie M; Wang Q; Fang Y; Dai Y; Zhai Y; Wang S; Yin C; Yang X
J Ovarian Res; 2017 May; 10(1):32. PubMed ID: 28472976
[TBL] [Abstract][Full Text] [Related]
4. Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementation.
Tsui KH; Lin LT; Horng HC; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):559-65. PubMed ID: 25510701
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Dehydroepiandrosterone (DHEA) to overcome the effect of ovarian ageing (DITTO): A proof of principle double blinded randomized placebo controlled trial.
Narkwichean A; Maalouf W; Baumgarten M; Polanski L; Raine-Fenning N; Campbell B; Jayaprakasan K
Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():39-48. PubMed ID: 28934714
[TBL] [Abstract][Full Text] [Related]
6. Protection of cumulus cells following dehydroepiandrosterone supplementation.
Lin LT; Wang PH; Chen SN; Li CJ; Wen ZH; Cheng JT; Tsui KH
Gynecol Endocrinol; 2017 Feb; 33(2):100-104. PubMed ID: 27684542
[TBL] [Abstract][Full Text] [Related]
7. Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles.
Zangmo R; Singh N; Kumar S; Vanamail P; Tiwari A
Reprod Biomed Online; 2014 Jun; 28(6):743-7. PubMed ID: 24745834
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.
Chern CU; Tsui KH; Vitale SG; Chen SN; Wang PH; Cianci A; Tsai HW; Wen ZH; Lin LT
Reprod Biol Endocrinol; 2018 Sep; 16(1):90. PubMed ID: 30223902
[TBL] [Abstract][Full Text] [Related]
9. DHEA restores mitochondrial dynamics of cumulus cells by regulating PGAM5 expression in poor ovarian responders.
Hou YL; Li CJ; Lin LT; Chen SN; Wen ZH; Tsui KH
Taiwan J Obstet Gynecol; 2022 Mar; 61(2):223-229. PubMed ID: 35361380
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone supplementation in women undergoing assisted reproductive technology with poor ovarian response. A prospective case-control study.
Al-Turki HA
J Int Med Res; 2018 Jan; 46(1):143-149. PubMed ID: 28758852
[TBL] [Abstract][Full Text] [Related]
11. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF.
Barad D; Gleicher N
Hum Reprod; 2006 Nov; 21(11):2845-9. PubMed ID: 16997936
[TBL] [Abstract][Full Text] [Related]
12. Does dehydroepiandrosterone supplementation really affect IVF-ICSI outcome in women with poor ovarian reserve?
Kara M; Aydin T; Aran T; Turktekin N; Ozdemir B
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():63-5. PubMed ID: 24331115
[TBL] [Abstract][Full Text] [Related]
13. Effects of dehydroepiandrosterone supplementation on women with poor ovarian response: A preliminary report and review.
Tsui KH; Lin LT; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):131-6. PubMed ID: 25951716
[TBL] [Abstract][Full Text] [Related]
14. DHEA protects mitochondria against dual modes of apoptosis and necroptosis in human granulosa HO23 cells.
Tsui KH; Wang PH; Lin LT; Li CJ
Reproduction; 2017 Aug; 154(2):101-110. PubMed ID: 28624766
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
[TBL] [Abstract][Full Text] [Related]
16. Dehydroepiandrosterone Shifts Energy Metabolism to Increase Mitochondrial Biogenesis in Female Fertility with Advancing Age.
Li CJ; Lin LT; Tsui KH
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371958
[TBL] [Abstract][Full Text] [Related]
17. Effects of dehydroepiandrosterone on in vivo ovine follicular development.
Narkwichean A; Jayaprakasan K; Maalouf WE; Hernandez-Medrano JH; Pincott-Allen C; Campbell BK
Hum Reprod; 2014 Jan; 29(1):146-54. PubMed ID: 24256992
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone decreases the age-related decline of the in vitro fertilization outcome in women younger than 40 years old.
Tartagni M; Cicinelli MV; Baldini D; Tartagni MV; Alrasheed H; DeSalvia MA; Loverro G; Montagnani M
Reprod Biol Endocrinol; 2015 Mar; 13():18. PubMed ID: 25884390
[TBL] [Abstract][Full Text] [Related]
19. Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria.
Xu B; Li Z; Yue J; Jin L; Li Y; Ai J; Zhang H; Zhu G
PLoS One; 2014; 9(6):e99858. PubMed ID: 24932478
[TBL] [Abstract][Full Text] [Related]
20. Does Dehydroepiandrosterone (DHEA) improve in vitro fertilisation (IVF) outcomes in poor responders?
Malini MN; Zain MM
Med J Malaysia; 2020 Jan; 75(1):24-28. PubMed ID: 32008015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
